Form D — Arcadia Biosciences, Inc.
0001469443-26-000002 · filed Jun 26, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Technology filings
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Reported offering amount
- $11,417,964
- Reported amount sold
- $3,999,613
- Minimum investment
- $0
- Investors
- 5
- Sales commission
- $395,000
- Finders' fees
- $0
Issuer
- Name
- Arcadia Biosciences, Inc.
- CIK
- 1469443
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 5956 SHERRY LANE
DALLAS, TX 75225 - Phone
- 214-974-8921
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Thomas J. Schaefer · Executive OfficerDallas, TX Find on LinkedIn ↗
-
Kevin Comcowich · DirectorDallas, TX Find on LinkedIn ↗
-
Amy Yoder · DirectorDallas, TX Find on LinkedIn ↗
-
Lilian Shackelford Murray · DirectorDallas, TX Find on LinkedIn ↗
-
Gregory D Waller · DirectorDallas, TX Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗